Back to Search
Start Over
Hepatic Macrophage as a Key Player in Fatty Liver Disease.
- Source :
- Frontiers in Immunology; 12/9/2021, Vol. 12, p1-16, 16p
- Publication Year :
- 2021
-
Abstract
- Fatty liver disease, characterized by excessive inflammation and lipid deposition, is becoming one of the most prevalent liver metabolic diseases worldwide owing to the increasing global incidence of obesity. However, the underlying mechanisms of fatty liver disease are poorly understood. Accumulating evidence suggests that hepatic macrophages, specifically Kupffer cells (KCs), act as key players in the progression of fatty liver disease. Thus, it is essential to examine the current evidence of the roles of hepatic macrophages (both KCs and monocyte-derived macrophages). In this review, we primarily address the heterogeneities and multiple patterns of hepatic macrophages participating in the pathogenesis of fatty liver disease, including Toll-like receptors (TLRs), NLRP3 inflammasome, lipotoxicity, glucotoxicity, metabolic reprogramming, interaction with surrounding cells in the liver, and iron poisoning. A better understanding of the diverse roles of hepatic macrophages in the development of fatty liver disease may provide a more specific and promising macrophage-targeting therapeutic strategy for inflammatory liver diseases. [ABSTRACT FROM AUTHOR]
- Subjects :
- FATTY liver
KUPFFER cells
LIVER cells
MACROPHAGES
NLRP3 protein
TOLL-like receptors
Subjects
Details
- Language :
- English
- ISSN :
- 16643224
- Volume :
- 12
- Database :
- Complementary Index
- Journal :
- Frontiers in Immunology
- Publication Type :
- Academic Journal
- Accession number :
- 154043988
- Full Text :
- https://doi.org/10.3389/fimmu.2021.708978